Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Avian Influenza
Applications of Hemopurifier expanded to include avian influenza
February 27th, 2006
Aethlon Medical, Inc., (AEMD) which develops therapeutic devices for infectious disease, is expanding the applications of its Hemopurifier treatment technology to include the H5N1 strain of the avian flu virus. The rapid progression of H5N1 infection allows only a brief treatment window with antiviral drugs. The Hemopurifier will target the direct capture of H5N1 and modulation of the immune response as a means to treat when drugs are ineffective or unavailable. In order to advance the H5N1 treatment application, Aethlon will manufacture and ship the treatment devices to established influenza researchers who will seek to establish the benefits of the Hemopurifier as a...
Source: Pharma Business Week (2006-02-27)
|
